These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetics of Behçet's disease: lessons learned from genomewide association studies. Gül A Curr Opin Rheumatol; 2014 Jan; 26(1):56-63. PubMed ID: 24257369 [TBL] [Abstract][Full Text] [Related]
3. The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing. Guasp P; Barnea E; González-Escribano MF; Jiménez-Reinoso A; Regueiro JR; Admon A; López de Castro JA J Biol Chem; 2017 Jun; 292(23):9680-9689. PubMed ID: 28446606 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Kirino Y; Bertsias G; Ishigatsubo Y; Mizuki N; Tugal-Tutkun I; Seyahi E; Ozyazgan Y; Sacli FS; Erer B; Inoko H; Emrence Z; Cakar A; Abaci N; Ustek D; Satorius C; Ueda A; Takeno M; Kim Y; Wood GM; Ombrello MJ; Meguro A; Gül A; Remmers EF; Kastner DL Nat Genet; 2013 Feb; 45(2):202-7. PubMed ID: 23291587 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive overview on the genetics of Behçet's disease. Mahmoudi M; Aslani S; Meguro A; Akhtari M; Fatahi Y; Mizuki N; Shahram F Int Rev Immunol; 2022; 41(2):84-106. PubMed ID: 33258398 [TBL] [Abstract][Full Text] [Related]
6. Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians. Sousa I; Shahram F; Francisco D; Davatchi F; Abdollahi BS; Ghaderibarmi F; Nadji A; Mojarad Shafiee N; Xavier JM; Oliveira SA Arthritis Rheumatol; 2015 Oct; 67(10):2742-8. PubMed ID: 26097239 [TBL] [Abstract][Full Text] [Related]
7. Behçet's Disease: An Overview of Etiopathogenesis. Leccese P; Alpsoy E Front Immunol; 2019; 10():1067. PubMed ID: 31134098 [TBL] [Abstract][Full Text] [Related]
8. New insights into the pathogenesis of Behçet's disease. Pineton de Chambrun M; Wechsler B; Geri G; Cacoub P; Saadoun D Autoimmun Rev; 2012 Aug; 11(10):687-98. PubMed ID: 22197900 [TBL] [Abstract][Full Text] [Related]
9. The immunogenetics of Behçet's disease: A comprehensive review. Takeuchi M; Kastner DL; Remmers EF J Autoimmun; 2015 Nov; 64():137-48. PubMed ID: 26347074 [TBL] [Abstract][Full Text] [Related]
10. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers. Takeuchi M; Ombrello MJ; Kirino Y; Erer B; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Watts NR; Gül A; Kastner DL; Remmers EF Ann Rheum Dis; 2016 Dec; 75(12):2208-2211. PubMed ID: 27217550 [TBL] [Abstract][Full Text] [Related]
11. Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease. Giza M; Koftori D; Chen L; Bowness P Clin Exp Immunol; 2018 Jan; 191(1):11-18. PubMed ID: 28898393 [TBL] [Abstract][Full Text] [Related]
12. Behçet's Disease: A Comprehensive Review on the Role of Khoshbakht S; Başkurt D; Vural A; Vural S Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003572 [TBL] [Abstract][Full Text] [Related]
13. [Behçet's disease from the aspect of autoinflammatory disease]. Ishigatsubo Y; Samukawa S Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):408-19. PubMed ID: 22041429 [TBL] [Abstract][Full Text] [Related]
14. Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches. Salmaninejad A; Gowhari A; Hosseini S; Aslani S; Yousefi M; Bahrami T; Ebrahimi M; Nesaei A; Zal M J Immunotoxicol; 2017 Dec; 14(1):137-151. PubMed ID: 28693405 [TBL] [Abstract][Full Text] [Related]
15. Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease. Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Shahram F; Meguro A; Mizuki N; Ahmadzadeh N; Jafarinejad-Farsangi S; Mostafaei S; Kavosi H; Faezi ST; Akhlaghi M; Davatchi F Sci Rep; 2018 Dec; 8(1):17612. PubMed ID: 30514861 [TBL] [Abstract][Full Text] [Related]
16. HLA and non-HLA genes in Behçet's disease: a multicentric study in the Spanish population. Montes-Cano MA; Conde-Jaldón M; García-Lozano JR; Ortiz-Fernández L; Ortego-Centeno N; Castillo-Palma MJ; Espinosa G; Graña-Gil G; González-Gay MA; Barnosi-Marín AC; Solans R; Fanlo P; Camps T; Castañeda S; Sánchez-Bursón J; Núñez-Roldán A; Martín J; González-Escribano MF Arthritis Res Ther; 2013 Oct; 15(5):R145. PubMed ID: 24286189 [TBL] [Abstract][Full Text] [Related]
17. The association of Behçet's syndrome with HLA-B51 as understood in 2021. Takeno M Curr Opin Rheumatol; 2022 Jan; 34(1):4-9. PubMed ID: 34690278 [TBL] [Abstract][Full Text] [Related]
18. The Impact of the 'Mis-Peptidome' on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response. Tedeschi V; Paldino G; Paladini F; Mattorre B; Tuosto L; Sorrentino R; Fiorillo MT Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348540 [TBL] [Abstract][Full Text] [Related]